ACD/Labs Streamlines LC/MS Peak Identification with ACD/Ion Presence™ Technology
Advanced Chemistry Development, Inc., (ACD/Labs) is pleased to announce ACD/Ion Presence™, the latest improvement to ACD/MS Manager software for processing, analyzing, and managing mass spectrometric data.
ACD/Ion Presence™ allows users to automatically find and label LC/MS peaks with a specified mass, and identify and label peaks with a user-specified difference from a reference mass value. This flexible new feature is useful for targeting the peaks for a parent drug and searching for expected metabolite transformations, for finding expected impurities, or for quickly identifying the targeted compound in high-throughput purity analysis. This automatic labeling feature allows users to quickly focus in on the peaks of interest. This feature enhances workflow as it can be applied to the extracted data at any time during data review without the need to perform data reprocessing.
Dr Mark Bayliss, Director of Analytical Informatics for ACD/Labs, adds, “ACD/Ion Presence peak labeling, combined with the highly sensitive LC/MS peak extraction algorithms contained in ACD/MS Manager, provides a flexible way to enhance searching for chromatographic peaks and masses of interest, simplifying the search for both major and minor components present in processed sample data.”
ACD/MS Manager may be seamlessly combined with other ACD/Labs product branches to combine chromatograms, NMR, UV-Visible, IR, and Raman spectra, and other analytical curves from all major instrument models and makes into a single data repository.
About Advanced Chemistry Development
Advanced Chemistry Development, Inc., (ACD/Labs) is a chemistry software company offering solutions that truly integrate chemical structures with analytical chemistry information to produce ChemAnalytics®. ACD/Labs creates innovative software packages that aid chemical research scientists worldwide with spectroscopic validation of structures, elucidation of unknown substances, chromatographic separation, medicinal chemistry, preformulation of novel drug agents, systematic nomenclature generation, and chemical patenting and publication. Founded in 1993, and headquartered in Toronto, Canada, ACD/Labs employs a team of over 120 dedicated individuals whose continual efforts carry ACD/Labs’ innovative technologies into pharmaceutical, biotech, chemical, and materials companies throughout the world. Information about Advanced Chemistry Development and its products is available at www.acdlabs.com .
